Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

Public health suffered several setbacks over the last week. First, the United States formally exited the World Health Organiza...

Impressions : 656

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

In 2022, Pfizer had crossed US$ 100 billion in revenue owing to its Covid products. While that was a one-off, Johnson & Johnson...

Impressions : 873

AbbVie inks US$ 5.6 bn oncology deal with China's RemeGen; Astra buys Modella AI to speed up cancer drug research

This week’s Phispers is packed with news from the ongoing JP Morgan Healthcare Conference (JPM26). Notably, AbbVie said i...

Impressions : 1084

Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines

The New Year began with two mid-size deals centered around the use of artificial intelligence (AI) in drug development. Sanofi...

Impressions : 884

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

AbbVie inks US$ 5.6 bn oncology deal with China's RemeGen; Astra buys Modella AI to speed up cancer drug research

Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines

Teva Pharms' Generics Amlodipine Besylate Receives Approval in US

Teva's Generics Ferric Citrate Receives Tentative Approval in US

Celltrion's Biologics Avtozma Receives Approval in US

Anthea Pharma's Generics Lacosamide Receives Approval in US

Ascent Pharms' Generics Buprenorphine HCl Receives Approval in US

Hisun Hangzhou's Generics Micafungin Receives Approval in US

Aurobindo's Generics Bisoprolol Fumarate Receives Approval in US

Teva' Generics Valbenazine Receives Tentative Approval in US

Macleods Pharms' Generics Fenofibrate Receives Approval in US

Somerset' Generics Sacubitril & Valsartan Receives Approval in US

Enforcement Report - Week of January 21, 2026

Enforcement Report - Week of January 14, 2026

Winder's Receives FDA Warning Letter

Chemspec Chemicals' Receives FDA Warning Letter

Purushothaman Damodara Kumaran's Receives FDA Warning Letter

Modern Recalls "Modern Warrior Ready" Dietary Supplement

Anthony Trinh Issues Nationwide Recall of Silintan Capsules

Asanuma Corporation is on FDA Import Alert List

FDA Issues Form 483 to Pure Indulgence Aesthetics

PLZ Corp. is on FDA Import Alert List

Drug Misuse: Govt May Curb 'Pregabalin' Sales

Aarti Pharmalabs Schedules Board Meet For Q Results

Mair Pharma Collaborates With Radboud Univ. On TMEM175 Agonists

J&J's Darzalex Faspro Notches Another Multiple Myeloma Indication

FDA Places Clinical Hold on Regenxbio's Rare Disease Program

Inventiva's 50% Surge Shows Investor Optimism Over Liver Drug

Tenpoint-Therapeutics-Receives US FDA Approval YUVEZZI

Cellares Attracts $257M Series D To Build Sites In Japan, Europe

Lilly Pens $1.1B Pact To Work On Hearing Loss Gene Editing Med

Repare Announces Completion of Acquisition by XenoTherapeutics

Alembic Gets USFDA Nod For Difluprednate Ophthalmic Emulsion

U.S. FDA Accepts Transpire Bio's ANDA for Generic Trelegy Filing

Sun Pharma Receives DCGI Approval For Generic Semaglutide

MNC's Cancer Drug Patent Rejected, Allowing Generics Entry

Aspire Biopharma Files Patent for Sublingual Generic Xanax(R)

SEC Recommends Three Firms For Semaglutide Formulations

Zydus Lifesciences Gets USFDA Nod For Generic Blood Disorder Drug

Zydus Receives Final Approval From USFDA For Eltrombopag Tablets

Apiject Opens U.S. Generic Injectable Facility in Apex, NC

Altanine's Outlook on Generics and Value-Added Formulations

Mair Pharma Collaborates With Radboud Univ. On TMEM175 Agonists

J&J's Darzalex Faspro Notches Another Multiple Myeloma Indication

Inventiva's 50% Surge Shows Investor Optimism Over Liver Drug

Lilly Pens $1.1B Pact To Work On Hearing Loss Gene Editing Med

Nautilus & Weill Medicine-Qatar Collaborate with Fox Foundation

Vera Therapeutics Names Matt Skelton as Chief Commercial Officer

Taiho Oncology Names Peter Melnyk President & CEO

Siren Advances To Clinical Stage With First FDA IND, Clearance

Sensorion Secures €60M Financing For Genetic Medicine Pipeline

Satellos Plans Share Consolidation For Nasdaq Listing

Siegfried to acquire high-quality small molecules drug substance

Minakem becomes DMF holder for five additional APIs

Korean CDMO ST Pharm Signs $56M Contract For API Production

HRV Pharma, Haleos Labs Partner on Partner on Orphan & niche APIs

Narmafotinib Large-Scale Manufacturing Complete

CDSCO OKs Most New r-DNA Drugs for 2025 Import & Manufacture

Sigachi Industries Reaches Key R&D Milestone In Cystic Fibrosis

Indian Pharma Urges Supply Chain Overhaul Amid Rising Tensions

Agno Pharma Acquires Actylis's CDMO Manufacturing Asset

Life Sciences Industry Urges Cybersecurity Funding, PLI Policy

Drug Misuse: Govt May Curb 'Pregabalin' Sales

Neogen Recalls Neogen Vet HYCOAT Hyaluronate Sodium Nationwide

China Halts Sale of Sun Pharma Drug Used to Treat Dementia

Sun Pharma, Cipla Recall U.S. Products Over Manufacturing Issues

NIH bans use of aborted fetal tissue in research

Haryana FDA Seizes Tapentadol And Pregabalin Stock In Sirsa

IPC Developing IP Reference Standards For Anti-Tb Drug

Over 160 Drug Samples Found Sub-Standard In December

LOTTE Biologics Strengthens Global Quality With Syracuse ADC Hub

FDA Proposes Febrile Seizure Warnings on Flu Shot Labels

Medable Launches AI Agent To Aid Principal Investigators In eCOA

Intelligent Bio Solutions Starts FDA 510(k) Studies

Fujirebio Expands Testing Portfolio With Lumipulse G pTau Assay